You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Acute-infarct selective cardiac MRI contrast agent

    SBC: ELGAVISH PARAMAGNETICS, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant The overall goal of this project is to demonstrate the ability of our acute myocardial infarct selective paramagnetic contrast agent Gadolinium ABE DTTA to differentiate between acute and chronic infarcts in a reliable manner using contrast enhanced magnetic resonance imaging ceMRI In our Phase I data we have shown that Gd ABE DTTA exclusively highlight ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  2. ADC IMMUNOTHERAPY USING REPLICONS WHICH ENCODE CYTOKINES

    SBC: REPLICON TECHNOLOGIES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  3. ADOLESCENT SKIN CANCER PREVENTION VIA GAMING TECHNOLOGY

    SBC: Henning Industrial Software,            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  4. Alkyl Phosphocholine and Phosphoethanolamine Detergents

    SBC: ANATRACE, INC.            Topic: N/A

    The understanding of protein function is greatly enhanced by the availability of three-dimensionalinformation obtained by X-ray crystallography. Unfortunately the large, well-ordered three-dimensionX-ray analyses have been difficult to produce for membrane proteins since they tend more naturally tdimensional arrays. A further complicating factor in dealing with membrane proteins is the requiremeso ...

    SBIR Phase II 1998 Department of Health and Human Services
  5. Ambulatory System for Hydrocephalus Shunt Monitoring

    SBC: H-CUBED            Topic: NINDS

    DESCRIPTION (provided by applicant): Each year, there are over 10,000 newborns diagnosed with hydrocephalus in the United States. Hydrocephalus, an excessive accumulation of cerebrospinal fluid (CSF) within the head, is a lifelong disease with no known cure. Fortunately, hydrocephalus can be managed with CSF shunts which redirect excessive CSF elsewhere in the body. Unfortunately, 30-40% o ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  6. A Nanofluidic Nanoplasmonic Platform for Multiplexing Detection of Cancer Biomark

    SBC: CFD RESEARCH CORPORATION            Topic: NCI

    DESCRIPTION (provided by applicant): This project aims to develop a novel nanofluidic-nanoplasmonic platform to realize multiplexed monitoring of biological binding processes, specifically for detection of cancer biomarkers in bio-fluids. In contrast to current large-sized, cumbersome surface plasmon resonance (SPR) sensing technology, the proposed device is comprised of a multilayer nanostructure ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  7. A Novel Expansion of Primary Leukemia Stem Cells

    SBC: Arteriocyte, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Arteriocyte's long-term objective is to develop a platform for ex vivo expansion of leukemic stem cell (LSC) based on cytokine-enriched medium and the company's proprietary nanofiber culture scaffold (NANEX). Cancer stem cell research is of significant importance because, this approach has the potential to create an effective therapy that overcomes challenges o ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  8. A Novel 'Zinc-Stapled' Long-Acting Insulin Analog

    SBC: THERMALIN DIABETES, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): A Phase 1 SBIR program of pre-clinical development is proposed focusing on a novel long-acting insulin analog for the basal treatment of diabetes mellitus. Designated Insulin-ZN, our product is a derivative of human insulin containing novel zinc-binding sites at the periphery of the insulin hexamer. The non-classical zinc-binding sites are mediated by paired (i ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  9. ANTIGEN SCANNING ON COMBINATORIAL ARRAYS

    SBC: H & N Instruments Inc            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  10. ANTIINFLAMMATORY AGENT FOR INFLAMMATORY BOWEL DISEASE

    SBC: Inotek Pharmaceuticals Corporation            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
US Flag An Official Website of the United States Government